**Upcoming Treatment Option for Graves’ Disease Shows Promise** Graves’ disease, an autoimmune disorder that primarily affects the thyroid gland, has...

# Effective Educational Strategies to Address and Reduce Vaccine Hesitancy ## Introduction Vaccine hesitancy, defined as the delay in acceptance...

**Phase IV Trial Shows Dovato’s Efficacy Comparable to Biktarvy: A New Milestone in HIV Treatment** In the ever-evolving landscape of...

**Understanding the Application of Good Manufacturing Practices (GMP)** Good Manufacturing Practices (GMP) are a set of guidelines and regulations that...

**How Generative AI is Transforming the Landscape of Clinical Trials** The advent of artificial intelligence (AI) has revolutionized numerous industries,...

**The Impact of Excessive Data: Evaluating Its Benefits and Challenges** In the digital age, data has become the lifeblood of...

**Adapting to Evolving Trends in Clinical Trials: A Catalyst for Innovation** Clinical trials are the cornerstone of medical advancements, providing...

**Phase III Clinical Trial Results Indicate Susvimo’s Potential Effectiveness in Treating Two Diabetic Eye Conditions** In a significant advancement for...

### Increased Risk of Dementia Linked to Traffic-Related Air Pollution #### Introduction Dementia, a debilitating condition characterized by a decline...

**Researchers Discover Speech Patterns Indicative of Future Cognitive Decline** In a groundbreaking study, researchers have identified specific speech patterns that...

**Researchers Discover Speech Pattern Linked to Early Cognitive Decline** In a groundbreaking study, researchers have identified specific speech patterns that...

**FDA Approves Investigational New Drug Application for Muscular Dystrophy Treatment** In a significant stride towards combating muscular dystrophy, the U.S....

**Addressing Obstacles in Conducting Critical Care Trials Amid the COVID-19 Pandemic** The COVID-19 pandemic has posed unprecedented challenges to global...

**Alert for Sites and Sponsors: Fake Job Applicants Could Pass Background Checks – ACRP** In an era where the digital...

**FDA Approves IND for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor, Enabling Phase I Clinical Trial** In a...

**Pharmaceutical Industry’s Perspectives on Artificial Intelligence Unveiled** The pharmaceutical industry, a cornerstone of modern healthcare, is undergoing a transformative shift...

# Utilizing eCOA Technologies to Enhance Patient-Centric Approaches in Healthcare In the rapidly evolving landscape of healthcare, patient-centric approaches have...

# Enhancing Clinical Research Results through Pharmacokinetics (PK) Clinical research is the backbone of medical advancements, providing the necessary data...

**Industry Experts Analyze the Effects of FDA’s Diversity Action Plan** In recent years, the U.S. Food and Drug Administration (FDA)...

**First Patient Receives Descartes-08 in Phase 2 Clinical Trial for Systemic Lupus Erythematosus** In a significant milestone for the treatment...

**First Patient Receives Descartes-08 in Phase 2 Clinical Trial for Systemic Lupus Erythematosus, Reports Drugs.com MedNews** In a significant milestone...

**National Institutes of Health Launches Phase I Trial to Evaluate Safety of Experimental Nasal COVID-19 Vaccine** In a significant stride...

**Guidelines for Safely Alleviating Your Baby’s Teething Pain** Teething is a significant milestone in your baby’s development, but it can...

**Comprehensive Guide to Hot Flashes: Causes, Symptoms, and Latest Research Insights – Seattle Clinical Research Center** Hot flashes are a...

**Comprehensive Guide to Hot Flashes: Causes, Symptoms, and Latest Research – Seattle Clinical Research Center** Hot flashes are a common...

**Key Factors to Consider When Integrating Artificial Intelligence** Artificial Intelligence (AI) has rapidly evolved from a futuristic concept to a...

### Five Clinical Research Studies Available for Men in Florida Clinical research studies are essential for advancing medical knowledge and...

**Promising New Small Molecule Treatment for Obesity Discovered** In recent years, the global obesity epidemic has emerged as a significant...

# Developing a Comprehensive Patient Experience Model to Enhance Medication Design and Interpretation In the rapidly evolving landscape of healthcare,...

**Rybrevant and Leclaza Demonstrate Superior Progression-Free Survival Compared to Tagrisso in Treating EGFR-Mutated Advanced NSCLC** In the ever-evolving landscape of...

Frequency of Citations in Future Research for Retracted microRNA Biomarker Articles

MicroRNAs (miRNAs) have gained significant attention in the field of biomarker research due to their potential role in various diseases, including cancer, cardiovascular diseases, and neurological disorders. However, the credibility of miRNA biomarker studies has come under scrutiny in recent years, with a growing number of articles being retracted due to issues such as data manipulation, lack of reproducibility, and ethical concerns.

A recent study published in the journal Nature Communications examined the frequency of citations in future research for retracted miRNA biomarker articles. The researchers analyzed a total of 50 retracted articles that were originally published between 2008 and 2018 and compared their citation rates to a control group of non-retracted articles.

The results of the study revealed that retracted miRNA biomarker articles continued to be cited in future research, with an average of 7.2 citations per retracted article compared to 11.4 citations per non-retracted article. This finding raises concerns about the impact of retracted articles on the scientific community and the potential for misinformation to be perpetuated in the literature.

One possible explanation for the continued citation of retracted miRNA biomarker articles is the lack of awareness among researchers about the retraction status of these studies. In many cases, retracted articles are not clearly marked as such in databases and may still appear in literature reviews and meta-analyses, leading to their continued use as references in new research.

Another factor that may contribute to the citation of retracted articles is the pressure to publish in academia. Researchers are often judged based on their publication record, and the inclusion of high-impact articles in their bibliography can enhance their reputation and career prospects. As a result, some researchers may be tempted to cite retracted articles without thoroughly vetting their credibility.

To address this issue, it is essential for journals and databases to clearly mark retracted articles and provide information about the reasons for retraction. Additionally, researchers should exercise caution when citing previous studies and verify the validity of the findings before incorporating them into their own research.

In conclusion, the frequency of citations in future research for retracted miRNA biomarker articles highlights the need for greater transparency and accountability in scientific publishing. By raising awareness about the pitfalls of citing retracted articles and promoting a culture of integrity and rigor in research, we can ensure that the scientific literature remains a reliable source of knowledge for future generations.